Outcomes of hospitalized patients with SARS-CoV-2 infection previously treated with renin-angiotensin system inhibitors

BACKGROUND: Renin angiotensin system inhibitors (RASi) are largely prescribed in hypertensive patients. As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) penetrates respiratory epithelium through angiotensin converting enzyme 2 (ACE2) binding, the association between RASi and poorer ou...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Archives of Cardiovascular Diseases. Supplements
Autors principals: Cordeanu, E., Jambert, L., Lambach, H., Tousch, J., Heitz, M., Mirea, C., Frantz, A.S., Younes, W., Delatte, A., Woehl, B., Bilbault, P., Ohlmann, P., Meziani, F., Andres, E., Stephan, D.
Format: Artigo
Idioma:Inglês
Publicat: Published by Elsevier Masson SAS 2021
Matèries:
462
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7803093/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.acvdsp.2020.10.143
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars